How much did Sedivention raise?

Sedivention raised $3.3M at Seed, announced 11 May 2026.

Who founded Sedivention?

Andreas Broecker is CEO & Co-founder of Sedivention.

What does Sedivention do?

Sedivention operates in HealthTech and is based in Germany.

FundedStartupsDaily / HealthTech / Sedivention

Sedivention raises $3.3M

Sedivention announced a Seed round of $3.3M on 11 May 2026. The company operates in HealthTech and is based in Germany. It was founded by Andreas Broecker, CEO & Co-founder.

Raised

$3.3M

Stage

Seed

Industry

HealthTech

Country

Germany

Founder

Andreas Broecker

CEO & Co-founder, Sedivention

LinkedIn profile sedivention.com

Outreach angles

-Andreas co-founded Sedivention with Dr. Ute Nollert in 2021, splitting time between Magdeburg and Munich to develop a one-time alternative to GLP-1 drugs.
-He returned for a Series-extension style seed alongside the strategic investment arm of a global medtech, validating Sedivention's cryo-ablation approach.
-The fresh €2.9M seed funds clinical development of a cryo balloon catheter that interrupts hunger signals in the vagus nerve in a single outpatient session.